Table 1 Characteristics of study populations (N = 574).

Male sex, n (%)

271 (82.6)

214 (87)

0.152

Age (years)*

52 (48–57)

53 (49–56)

0.695

IDU^a, n (%)

205 (66.3)

209 (87.1)

0.001

Alcohol intake ≥50 g/d, n (%)

168 (51.2)

60 (24.4)

<0.001

HCV Genotype 3 infection, n (%)

54 (16.5)

43 (17.5)

0.748

BMI^b (kg/m²)*

25.9 (22.6–28.5)

24 (21.3–27)

0.001

   18–25

141 (44.3)

144 (60.3)

0.004

   26–30

123 (38.7)

67 (28)

   31–35

41 (12.9)

18 (7.5)

   >35

11 (3.5)

9 (3.8)

Fasting plasma glucose^c ≥100 mg/dL, n (%)

72 (24.4)

75 (30.5)

0.113

Plasma triglycerides^d ≥150 mg/dL, n (%)

42 (14.1)

82 (33.5)

0.001

Plasma total cholesterol^e (mg/dL)*

165 (145–199)

156 (137–182)

0.001

Plasma HDL-cholesterol^f (mg/dL)*

52.5 (41.5–65.4)

47.5 (37.6–59.0)

0.003

Plasma LDL-cholesterol^g (mg/dL)*

91 (71–115)

76 (61–99)

0.001

LS (kPa)*

7.3 (5.4–13.3)

9.7 (6.9–16.9)

0.001

Cirrhosis, n (%)

78 (23.8)

80 (32.5)

0.020

HbsAg^h+, n (%)

1 (0.3)

8 (3.3)

0.001

CD4 cell counts/mm³)^I *

—

486 (310.5–726.0)

Plasma HIV-RNA < 50 copies/mL, n (%)

—

194 (78.9)

ART^j, n (%)

—

241 (99.2)